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The accurate characterization and description of the vascular network of a cancer lesion is of 
paramount importance in clinical practice and cancer research in order to improve diagnostic 
accuracy or to assess the effectiveness of a treatment. The aim of this study was to show the 
effectiveness of liposomes as an ultrasound contrast agent to describe the 3-D vascular archi-
tecture of a tumor. Eight C57BL/6 mice grafted with syngeneic B16-F10 murine melanoma 
cells were injected with a bolus of 1,2-Distearoyl-sn-glycero-3-phosphocoline (DSPC)-based 
non-targeted liposomes and with a bolus of microbubbles. 3-D contrast-enhanced images of 
the tumor lesions were acquired in three conditions: pre-contrast, after the injection of micro-
bubbles, and after the injection of liposomes. By using a previously developed reconstruction 
and characterization image processing technique, we obtained the 3-D representation of the 
vascular architecture in these three conditions. Six descriptive parameters of these networks 
were also computed: the number of vascular trees (NT), the vascular density (VD), the number 
of branches, the 2-D curvature measure, the number of vascular flexes of the vessels, and the 
3-D curvature. Results showed that all the vascular descriptors obtained by liposome-based 
images were statistically equal to those obtained by using microbubbles, except the VD which 
was found to be lower for liposome images. All the six descriptors computed in pre- contrast 
conditions had values that were statistically lower than those computed in presence of con-
trast, both for liposomes and microbubbles. Liposomes have already been used in cancer 
therapy for the selective ultrasound-mediated delivery of drugs. This work demonstrated their 
effectiveness also as vascular diagnostic contrast agents, therefore proving that liposomes 
can be used as efficient “theranostic” (i.e. therapeutic 1 diagnostic) ultrasound probes.
Key words: Contrast-enhanced ultrasounds; Molecular imaging; Skeletonization; Distance 
transform; Microbubbles; Liposomes; Vascular descriptors; Vascular architecture.
Introduction
Sonography is a non-invasive imaging modality allowing the real-time visual-
ization of cancer lesions in almost any organ of the human body, except lungs 
and the gastric tract (where the presence of air could limit the propagation of the 
ultrasound waves). Due to their excellent penetration capabilities,  sonography has 
been used to visualize thyroid (1, 2), pancreas (3), liver (4), prostate (5), ovarian 
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(6, 7), breast (8), and brain (9) cancers. When used in tra-
ditional B-mode modality, sonographic devices show a gray 
image in which the pixel intensity (brightness) is proportional 
to the logarithmic amplitude of the ultrasound echo generated 
in that portion of tissue. In cancer diagnosis, B-mode imaging 
allows detection of the presence of a lesion. A sample image 
of a mouse syngeneic cancer model (C57BL/6 mouse with 
subcutaneous grafting of B16-F10 murine syngeneic mela-
noma cancer cells) is shown in Figure 1A. When used in Dop-
pler modality, sonographic devices also allow the observation 
of blood flow velocity, since the gray B-Mode image is over-
laid by a color map showing either the direction and the value 
of the blood flow (Color Doppler mode) or just the value of 
the blood flow (Power Doppler mode). Color and Power Dop-
pler images are, however, limited in resolution and cannot 
detect blood flows in microvasculature (10) ( Figure 1B). 
Previous works have shown that the characterization of can-
cer lesion vascular patterns are not possible with  Doppler 
imaging alone, because of the lack of spatial resolution 
(11, 12). Contrast-enhanced ultrasound (CEUS) imaging can 
be used to effectively assess the vascularization of tumors 
in vivo (13, 14). CEUS imaging relies on second harmonic 
non-linear imaging (Figure 1C). In this image, the signal is 
spontaneously generated by the non-linear behavior of both 
tissues and blood (15). However, second harmonic imag-
ing mainly exploits the non-linear properties of the contrast 
agent, consisting of gas-filled microbubbles. Such micro-
bubbles have an average diameter of about 5 μm and do not 
extravasate, but they have limited duration in the blood flow 
(16). A sample of CEUS imaging is shown in Figure 1D. 
3-D CEUS imaging allows an accurate reconstruction of 
 cancer vascular patterns (17, 18). Huang et al. showed that it 
is possible to reconstruct the spatial vascular pattern of breast 
cancer lesions by using 3-D ultrasound imaging (19, 20). 
Their approach consisted of two steps: first the Power Dop-
pler images were segmented in order to detect only the voxels 
Figure 1: Ultrasound images of a mouse tumor (C57BL/6 mouse with subcutaneous grafting of syngeneic melanoma induced by B16-F10 cancer cells). 
(A) High-resolution B-mode, (B) Power Doppler, (C) Second harmonic non-linear spontaneous signal, and (D) CEUS image after injection of microbubbles. 
The white arrows indicate the cancer lesion borders.
CEUS Skeletonization for Cancer Vascularization Quantification 543
Technology in Cancer Research & Treatment, Volume 13, Number 6, December 2014
in which blood flow was present, and then the set of voxels 
was post-processed by thinning algorithms in order to recon-
struct the internal vascular architecture. In 2010, Molinari 
et al. proposed a quantitative approach for the characteriza-
tion of thyroid nodules that was based on 3-D CEUS imaging 
(18). The 3-D representation of the tumor vascularization can 
also be characterized by computing numerical features of the 
vascular pattern, such as the number of vascular trees (NT), 
the number of vascular branches, and the tortuosity of the 
vessels (18). Acharya et al. then showed that such numerical 
CEUS features could be used for the differential diagnosis of 
malignant lesions w.r.t. benign ones (1, 21). 
Liposomes, which are nano-sized vesicles, are widely used 
in medicine as drug carriers, mostly in cancer therapy (22, 
23). Recently, researchers have been facing the challenge of 
developing innovative strategies to provide an imaging sup-
port to therapies, including the design of probes for the in vivo 
visualization of drug delivery and release (24, 25). This field 
is called “theranosis”, which comes from merging the words 
“therapy” and “diagnosis”, and it indicates the use of the 
same agent for diagnosis and therapy (26). Liposomes play 
a relevant role in this emerging research field, mainly thanks 
to the fact that they are very versatile and can therefore be 
loaded with drugs and diagnostic agents that present different 
physico-chemical characteristics. Therefore, liposomes pres-
ent the characteristics of a probe that can potentially be used 
to both characterize and treat a cancerous lesion. 
The aim of this study was to quantitatively compare tumor 
vascular patterns as assessed by 3D CEUS when using tradi-
tional microbubbles and liposomes. The study was conducted 
on animal models using dedicated ultrasound equipment, 
however the processing technique used is general and easily 
adaptable to human studies.
Methods
Liposomes Preparation
DSPC1 liposomes were prepared using the thin film 
 hydration method. The total amount of lipidic material 
was 50 mg/mL. The liposomes were formulated as follows: 
DSPC/ DSPE-PEG20002 (95/5 molar ratio). Chemicals were 
purchased from Avanti Polar Inc. (Alabaster, AL, USA). 
The thin lipid film was hydrated with a 300 mM solution of 
the clinically approved MRI agent Gadoteridol (marketed 
by Bracco Imaging as ProHanceTM) and the so-obtained 
suspension was extruded several times on polycarbonate 
filters. The mean hydrodynamic liposomes diameter was 
160 6 10 nm (determined by dynamic light scattering) and 
the final concentration of Gadoteridol in the liposomes sus-
pension was 30 mM. We used liposomes with an internal 
core of an MRI contrast agent because in another related 
study we showed that these liposomes were visible by ultra-
sound imaging and that their release could be controlled by 
non-focused  ultrasounds (22).
Experimental Protocol
We tested eight C57BL/6 male mice (10 weeks old, weight 
23 6 4 g) purchased from Charles River Laboratories 
(Calco, Lecco, Italy). B16-F10 murine melanoma cells, cul-
tured in RPMI 1640 medium supplemented with 10% (v/v) 
heat- inactivated fetal calf serum, 100 UI/mL penicillin, and 
100 mg/mL streptomycin, were inoculated 1 3 106 in 0.2 mL 
PBS subcutaneously to obtain a syngeneic melanoma in the 
rear thigh of the mice. All the experiments were performed 
around 1 week after the injection, when the tumor’s  maximum 
diameter reached about 8 mm.
The mice were sedated by gaseous anaesthesia according to 
the protocols for preclinical studies (27). Ultrasound exami-
nations were performed with a VEVO2100 system (Fujifilm 
VisualSonics, Toronto, Canada) equipped with a 24 MHz 
linear probe. Traditional high-resolution ultrasound (HRUS) 
images were acquired, along with 3-D CEUS images of the 
tumor. First we acquired a basal 3-D HRUS and CEUS image 
of the lesion (without any contrast). Then we injected a 50 μL 
bolus of non-targeted Vevo MicroMarker (Bracco, Geneve) 
optimized for use on the Visualsonics HR Micro-Ultrasound 
System VEVO2100. 40 μL of saline solution was injected 
right after the contrast agent bolus. We then acquired the 3-D 
HRUS and CEUS images. After waiting for the complete 
destruction of the microbubbles (about 30 minutes), a 200 μL 
bolus of the above described liposomes was then injected, fol-
lowed by 40 μL of saline solution. After the liposomes injec-
tion, we again acquired the 3-D HRUS and CEUS images. 
The Gain and Time Gain Compensation (TGC) settings of 
the ultrasound system were kept the same for all exams.
Experiments were performed according to the national regu-
lations and were approved by the local animal experiments 
ethical committee.
Pre-processing and Skeletonization Strategy
The pre-processing strategy of the images was the same for 
the three different 3-D CEUS volumes. The pre-processing 
steps are fully described in a previous work (18), and is sum-
marized here in Figure 2. The first column of Figure 2 reports 
the processing steps applied to the pre-contrast CEUS image 
11,2-Distearoyl-sn-glycero-3-phosphocoline (DSPC)
21,2 Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000]Ammonium salt (DSPE-PEG2000)
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Figure 2: Pre-processing architecture. The first column is relative to a central slice of the tumor before injection of any contrast, the second to the injection 
of microbubbles, and the third to the injection of liposomes. The rows report the pre-processing steps (from top to bottom): the raw image, the intensity normal-
ized image, the filtered image, the morphologically opened image, and the result of the segmentation based on Otsu’s thresholding.
(i.e. before the injection of any contrast), the middle  column 
is relative to the CEUS image acquired after the  injection 
of microbubbles, and the rightmost column is relative to 
the injection of liposomes. Only the central slice of the 
3-D  volumes is represented. The cancer lesion and the slice 
are the same in all three columns. The rows of Figure 2 
report the sequence of the pre-processing steps. The first row 
shows the raw CEUS image; the second row portrays the 
image after intensity normalization; and the third row image 
after low-pass filtering (Gaussian filtering with a 3 3 3 
kernel and s 5 1). After filtering, the images were morpho-
logically opened in order to emphasize the intensity signal 
given by the contrast agent (fourth row of Figure 2). We used 
a structuring element of 1 pixel radius, because it resembled 
the shape of a bubble.
Each slice was then segmented by using Otsu’s thresholding 
(28). The bottom row of Figure 2 reports the segmentation 
mask, in which the white region indicates the presence of 
contrast agent. 
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Once the slices were processed and segmented, we applied 
a skeletonization process to reduce the representation of the 
vascular network. The skeletonization procedure aims at 
reducing the image into a minimal representation that still 
preserves morphology (29). This skeleton-based approach 
has already been used in previous ultrasound studies (12, 18), 
in which there was the need to reduce the representation of 
the blood vessels without losing the architectural features of 
the vascular pattern. Our skeletonization procedure consisted 
in two cascaded steps:
1 We first adopted a geometrical skeleton based on 
the distance transform (DT) (30). The DT of a point 
belonging to an object is defined as its minimal dis-
tance from the closest border of the object itself. 
Hence, points located in the middle of a vessel have 
high DT values, whereas points located near the vessel 
borders have lower DT values. Therefore, a DT skel-
eton can be obtained by simply imposing a threshold 
on the DT of an image, thus preserving the innermost 
points of the objects. The higher the threshold, the 
thinner the object representation will be. In previous 
works, we showed that a suitable value for CEUS DT 
skeletons is 0.55 (18). Figure 3 sketches the skeletoni-
zation process. In particular, Figure 3B shows the DT 
skeleton obtained by the segmented CEUS image of 
Figure 3A.
2 The DT skeleton was then thinned even more with 
the use of a topological skeleton. We used the skel-
eton proposed by Ma and Sonka (29). Topological 
skeletons are based on a series of 3 3 3 3 3 masks. 
These masks describe all the possible conditions to 
consider a pixel as a “border” pixel. Hence, if the 
3 3 3 3 3 neighborhood of a pixel matches one of 
the masks, that pixel is located on the border of an 
object and can thus be deleted. Full details about the 
Ma and Sonka algorithm (29) can also be found in the 
study by Palàgyi and Kuba (31), in which 38 masks 
were used. Figure 3C reports the topological skeleton 
obtained from the DT skeleton of Figure 3B. Figure 
3D shows the final skeleton in red overlaid on top of 
the original CEUS image.
Figure 3: Skeletonization process. This sample is relative to the injection of microbubbles. (A) Pre-processed image (same as Figure 2, middle column, 
 bottom row), (B) Application of the Distance Transform geometric skeleton, (C) Application of the topological skeleton, and (D) Final skeleton (in red) 
 overlaid on the original CEUS image.
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Vascular Pattern Characterization
Basically, the obtained 3-D skeletons are volumetric binary 
images containing a network of vessels. Therefore, such 
networks can be analyzed in order to numerically describe 
the represented vascular pattern. Each 3-D skeleton was 
hence analyzed by the Breadth First Search (BFS) algo-
rithm (32). Since cancer lesions can have different sizes, 
we analyzed a Region-of-Interest (ROI) of 50 3 50 3 20 
pixels, in order to standardize the quantification of the vas-
cular pattern. We chose this size because it was compatible 
with the dimensions of all the cancer lesions of our dataset. 
Figure 4 shows the positioning of the ROI with respect to 
the 3-D skeleton. The positioning of the ROI was made 
manually.
 Euclidean distance between the first and last point of 
the curve. The DM value of a straight line would be 
equal to 1, but it would assume higher values as the 
curvature increases.
5 Inflection count metric (ICM): Defined as the number 
of flexes of a curve. This is another measurement of 
vessel tortuosity.
6 3-D sum of angles metric (SOAM): Defined as the sum 
of all the angles that a curve has in space. 
The mathematical description of these parameters can be 
found in previously published papers (18, 19). By summa-
rizing, we characterized the vascular complexity by three 
morphological parameters (NT, VD, and NB) and by three 
curvature/tortuosity parameters (DM, ICM, and SOAM).
Results
The advantages of the proposed two-step skeletonization 
architecture are:
1 Prevention of vessel disconnections, because the DT 
skeleton cannot create disconnections unless a wrong 
(i.e. too high) threshold is selected;
2 Reduction of the computational cost, because the com-
putationally expensive topological skeleton is applied 
to an already reduced set of voxels.
Figure 5 reports the obtained skeletons from the three sets 
of CEUS images for a cancer lesion of our dataset. The first 
column of Figure 5 is relative to the tumor before injection 
of any contrast, the second to the injection of microbubbles, 
and the third to the injection of liposomes. The first row 
 Figure 5 portrays the original CEUS images (central slice 
of the tumor); the second row reports the corresponding 
skeletonized images; the bottom row instead shows the 3-D 
reconstructed skeletons. It is possible to observe that the 3-D 
skeletons obtained after injections of microbubbles or lipo-
somes are very rich and represent the intra-lesion vasculature 
very nicely. Conversely, the skeleton obtained from the raw 
CEUS images without any contrast is limited to the periphery 
of the lesion, and there is no representation of the internal 
vessels.
Table I reports the average values of the vascular descriptors. 
The values were measured on the 3-D CEUS volumes after 
skeletonization.
The first comparison is between the vascular descriptors 
obtained by using liposomes and microbubbles (second 
and third rows). The asterisks in Table I denote the descrip-
tors that were not statistically different between the 3-D 
microbubbles and 3-D liposomes CEUS skeletons (paired 
Student’s t-test; p  0.05). Five out of six descriptors were 
Figure 4: Manual positioning of the Region-of-Interest (ROI) in the center 
of the 3-D skeleton. The ROI size was 50 3 50 3 20 pixels.
Starting from an initial voxel, the BFS algorithm navigates 
the entire skeleton by following the vessels. The BFS marks 
each voxel as visited and iterates until all voxels of the skel-
eton have been visited at least once. The BFS algorithm is 
able to search all of the vessels in the skeleton and during 
this search, quantitative parameters can be computed. The 
six parameters that we considered indicative of the vascular 
 pattern were:
1 Number of vascular trees (NT): Defined as the num-
ber of trees in which the BFS decomposes the skeleton 
image.
2 Vascular density (VD): Defined as the number of skel-
eton voxels compared to the volume of the selected 
ROI.
3 Number of branching nodes (NB): Defined as the num-
ber of branches of the structure.
4 2-D distance metric (DM): A measure of the bidimen-
sional tortuosity of a vessel. Considering a curved 
line representing the vessel, the DM is defined as the 
ratio between the actual length of the curve and the 
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not statistically different, whereas one (VD) was higher 
for microbubbles than for liposomes (p 5 0.01). The aver-
age NT detected in the ROIs from 3-D CEUS skeletons 
obtained after the injection of microbubbles was equal 
to 39.5 6 17.5 (38.1 6 17.2 after liposomes injection), 
whereas the average NB was 1096 6 357 (695 6 450 
after liposomes injection). The three curvature/tortuosity 
descriptors were equal to 23.70 6 3.57 (DM), 7.86 6 3.57 
(ICM), and 12.17 6 6.41 (SOAM) for microbubbles-based 
skeletons. For liposomes-based skeletons the three descrip-
tors had the following respective values: 23.11 6 12.08 
(DM), 9.88 6 5.45 (ICM), and 11.08 6 6.00 (SOAM). It 
is, therefore, possible to notice that the values reported by 
both the second and third rows are very close, thus dem-
onstrating the effectiveness of liposomes as a potential 
alternative to microbubbles for the quantification and char-
acterization of cancer vascularization with 3-D ultrasound 
images.
The second comparison is among the vascular descrip-
tors measured by the pre-contrast skeletons and the respec-
tive descriptors measured after microbubbles or liposomes 
injection. The values of the six descriptors measured in 
pre- contrast conditions were: 14.3 6 6.2 (NT), 0.01 6 0.01 
(VD), 188 6 146 (NB), 8.39 6 4.26 (DM), 3.76 6 2.73 
(ICM), 4.49 6 3.08 (SOAM). All the descriptor values were 
statistically lower in the pre-contrast condition than in the 
contrast condition (paired Student’s t-test; always p  0.05), 
independently on the type of contrast (i.e. microbubbles or 
liposomes).
Figure 5: Representation of the final 3-D skeletons. The first column is relative to the tumor before injection of any contrast, the second to the injection of 
microbubbles, and the third of liposomes. The first row reports the original CEUS image (central slice of the tumor); the second row reports the corresponding 
skeletonized image; the bottom row reports the 3-D reconstructed skeleton.
Table I
Average values of the six descriptors of the vascular patterns as measured from the 3-D CEUS skeletons. 
NT* VD NB* DM* ICM* SOAM*
Pre-contrast 14.3 6 6.2 0.01 6 0.01  188 6 146 8.39 6 4.26 3.76 6 2.73 4.49 6 3.08
Microbubbles 39.5 6 17.5 0.07 6 0.01 1096 6 357 23.70 6 3.57 7.86 6 3.57 12.17 6 6.41
Liposomes 38.1 6 17.2 0.05 6 0.03  695 6 450 23.11 6 12.08 9.88 6 5.45 11.08 6 6.00
*The descriptors that were not statistically different between microbubbles and liposomes (paired Student’s t-test; 
p  0.05).
Abbreviations: NT: Number of Vascular Trees; VD: Vascular Density; NB: Number of Branching nodes; DM: 2-D 
Distance Metric; ICM: Inflection Count Metric; SOAM: 3-D Sum of Angles Metric.
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Discussion
The reconstruction and numerical characterization of a tumor 
lesion vasculature could be very useful in practical applica-
tions, in basic research, and in pharmacological and onco-
logical applications. Previous studies have demonstrated that 
the characterization of the internal vascularization of breast 
lesions could be useful in clinical practice to aid the differen-
tial diagnosis between benign and malignant lesions. Huang 
et al. showed that the descriptors of the vascular architec-
ture of a lesion could be used to assess malignancy in breast 
lesions (19). They used 3-D volumes obtained by Power 
Doppler imaging, therefore their data were mainly relative 
to macro-vessels. They showed that malignant lesions had 
higher values of the vascular descriptors. This is due to the 
fact that tumor angiogenesis creates new vessels with a high 
number of branches, and that the neo-formed vessels are 
usually coiled. More recently, the same team showed that 
malignant lesions can be efficiently detected by compar-
ing the vascular descriptors of the suspected lesion with the 
descriptors measured on a portion of healthy tissue taken as 
reference (20). Molinari et al. applied a similar technique to 
show the difference between the intranodal vascularization of 
benign and malignant thyroid lesions (18), and they demon-
strated that the numerical values of the vascular descriptors 
measured by the skeletons are higher for malignant lesions 
than for benign lesions. Molinari et al. used CEUS imag-
ing (18), thus showing the effectiveness of this approach to 
describe the micro-vascularization of a tumor. Therefore, this 
combined approach of 3-D reconstruction and description of 
the vascular architecture finds its application in the field of 
cancer research and treatment.
In this work, conducted on animal models, we showed that 
the injection of a bolus of liposomes produces CEUS 3-D 
volumes that are suitable for the reconstruction and charac-
terization of the microvascularization of a lesion. We dem-
onstrated that the 3-D skeletons depicting the intra-lesion 
vascular network obtained after liposomes injection are very 
similar to those obtained after injecting the traditional sono-
graphic contrast agent consisting of gaseous microbubbles. 
We reconstructed the skeleton of the vascular network of 
eight mice by injecting microbubbles and liposomes sepa-
rately, and then showed that the numerical values of the vas-
cular descriptors were on average not statistically different. 
Specifically, we showed that the NT, the number of branches, 
and the curvature and tortuosity indexes were not statistically 
different when measured after microbubbles or liposomes 
injection (Table I). 
We found that one out of six parameters (VD) was statistically 
lower for liposome-based skeletons than for microbubbles 
skeletons. This result was most likely due to the type of lipo-
somes that were used. The DSPC liposomes used in this work 
likely generated a non-optimal ultrasound signal. Numeri-
cally, the average VD measured from 3-D liposome-based 
CEUS images was not very different from that measured 
from microbubbles-based images, but the standard deviation 
was three times higher (Table I). Additionally, the ultrasound 
equipment used was specifically optimized for the Vevo 
MicroMarker microbubbles and produced images with higher 
echogenicity. Hence, it is likely that a suboptimal sonographic 
response of our liposomes, which produced images with lower 
echogenicity, gave forth a lower VD average value. 
An improved echogenicity of the liposomes could be obtained 
by changing the liposomal formulation in terms of membrane 
and core composition. Alternatively, echogenic liposomes 
(ELIP), i.e. liposomes loaded with a mixture of gas and 
water, could also be tested; however, these liposomes have 
a more difficult preparation process and often tend to pres-
ent a large variability in their size (33). The latter issue may 
significantly limit the performance of the probe due to the 
fact that large nanoparticles (diameter  200 nm) reduce the 
vascular extravasation (34), thereby decreasing considerably 
their usefulness in cancer therapy. Furthermore, ELIP are 
not approved for clinical use yet, contrarily to  conventional 
liposomes.
Nevertheless, to the best of our knowledge, this study is the 
first one demonstrating that it is possible to accurately recon-
struct and describe the vascular architecture of a cancer lesion 
by using liposomes and 3-D non-linear ultrasound imaging. 
Some very recent studies adopted a CEUS based methodol-
ogy to improve the assessment of cancer lesions. Specifically, 
Grouls et al. used non-targeted microbubbles and clinically 
translatable PEGylated targeted microbubbles for the vascu-
lar endothelial growth factor receptor type 2 (35). They quan-
tified the microbubbles kinetics in the lesion and showed that 
targeted microbubbles enabled the distinction between early 
stages of liver dysplasia and a normal liver. In our study, we 
used stealth non-targeted liposomes. Therefore, we believe 
that our technique could have further scopes of improvement 
if echogenic and targeted liposomes were used.
Our technique has some limitations that we will discuss here 
in the following. From a technical point of view, the proce-
dure is not fully automated yet. The pre-processing and skel-
etonization steps are automated and user-independent, but 
manual placing of the analysis ROI (Figure 4) is required. 
Different placements of the ROI could lead to different vas-
cular parameters. In pilot experiments (not reported in this 
paper) we observed a very low intra-operator variability 
(lower than 0.1% for all the six parameters). Our team has 
already developed a fully automated version of this proce-
dure that will remove this limitation. The new procedure will 
incorporate an automated segmentation of the tumor in the 
3-D HRUS images. The segmentation mask will be applied 
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to the 3-D CEUS volume, in order to automatically determine 
the entire lesion volume. Another limitation of this study is 
given by the kinetics of the liposomes in the tumor environ-
ment (36). Since liposomes might extravasate, their non- 
linear signal could become inaccurate in certain conditions. 
In fact, smaller nanoparticles have a higher therapeutic effect, 
but they generate a lower ultrasound signal. Liposomes with 
an average size of 200 nm might be the best compromise. We 
are currently studying the liposomes kinetics in tumor envi-
ronment by using ultrasounds, in order to further optimize the 
CEUS acquisition modality.
Conclusions
In this paper, we showed that liposome-based 3-D CEUS 
images are suitable to accurately reconstruct and numeri-
cally describe the vascular network of tumor lesions. Our 
integrated technique was based on image processing, skel-
etonization, and characterization and can describe morpho-
logical and geometrical aspects of the vessel network. Even 
though this study was conducted in a pre-clinical environ-
ment, we believe that this approach could be easily translated 
to human applications in the near future. Our theranostic 
technique could be useful for the characterization of tumor 
types, for the differential diagnosis of suspected lesions, and 
for the assessment of the effect of anti-cancer drugs (i.e. anti- 
angiogenetic drugs).
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